Prediction of Conserved HLA Class I and Class II Epitopes from SARS-CoV-2 Licensed Vaccines Supports T-Cell Cross-Protection against SARS-CoV-1
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details